

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.51315344 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 5.26771710 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.17626971 |
| 4 | DNA deamination (GO:0045006) | 5.16278922 |
| 5 | formation of translation preinitiation complex (GO:0001731) | 4.98805326 |
| 6 | viral transcription (GO:0019083) | 4.97151121 |
| 7 | translational termination (GO:0006415) | 4.88648560 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.72309968 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.72309968 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 4.65595625 |
| 11 | ribosomal large subunit biogenesis (GO:0042273) | 4.64189428 |
| 12 | regulation of mitochondrial translation (GO:0070129) | 4.44220005 |
| 13 | translational elongation (GO:0006414) | 4.43602239 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 4.42856992 |
| 15 | translational initiation (GO:0006413) | 4.38485953 |
| 16 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.27653005 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.26577305 |
| 18 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.23404588 |
| 19 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.19575121 |
| 20 | ribosome assembly (GO:0042255) | 4.13587408 |
| 21 | * nucleobase biosynthetic process (GO:0046112) | 4.10372577 |
| 22 | proteasome assembly (GO:0043248) | 4.08599118 |
| 23 | protein targeting to ER (GO:0045047) | 4.08290106 |
| 24 | ribosome biogenesis (GO:0042254) | 4.08112589 |
| 25 | cotranslational protein targeting to membrane (GO:0006613) | 4.06940386 |
| 26 | DNA strand elongation (GO:0022616) | 4.04650825 |
| 27 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.04002550 |
| 28 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.95948085 |
| 29 | DNA replication initiation (GO:0006270) | 3.94825673 |
| 30 | * purine nucleobase biosynthetic process (GO:0009113) | 3.89446471 |
| 31 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.87834857 |
| 32 | cellular protein complex disassembly (GO:0043624) | 3.87761208 |
| 33 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.87018767 |
| 34 | protein localization to endoplasmic reticulum (GO:0070972) | 3.86427233 |
| 35 | viral life cycle (GO:0019058) | 3.86029842 |
| 36 | respiratory electron transport chain (GO:0022904) | 3.81852017 |
| 37 | rRNA processing (GO:0006364) | 3.80576859 |
| 38 | DNA replication checkpoint (GO:0000076) | 3.74303786 |
| 39 | electron transport chain (GO:0022900) | 3.74086017 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.71201308 |
| 41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.71139890 |
| 42 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.70503980 |
| 43 | protein targeting to mitochondrion (GO:0006626) | 3.70461180 |
| 44 | rRNA metabolic process (GO:0016072) | 3.65699406 |
| 45 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.64330402 |
| 46 | termination of RNA polymerase III transcription (GO:0006386) | 3.64330402 |
| 47 | protein complex biogenesis (GO:0070271) | 3.62830504 |
| 48 | translation (GO:0006412) | 3.62803423 |
| 49 | telomere maintenance via recombination (GO:0000722) | 3.61298734 |
| 50 | pseudouridine synthesis (GO:0001522) | 3.58625605 |
| 51 | spliceosomal snRNP assembly (GO:0000387) | 3.57133661 |
| 52 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.56912155 |
| 53 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.56333787 |
| 54 | rRNA modification (GO:0000154) | 3.55309098 |
| 55 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.55074797 |
| 56 | negative regulation of ligase activity (GO:0051352) | 3.55074797 |
| 57 | protein targeting to membrane (GO:0006612) | 3.53002208 |
| 58 | CTP biosynthetic process (GO:0006241) | 3.51123550 |
| 59 | CTP metabolic process (GO:0046036) | 3.51123550 |
| 60 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.48982579 |
| 61 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.46877876 |
| 62 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.46866401 |
| 63 | base-excision repair, AP site formation (GO:0006285) | 3.46653934 |
| 64 | mitotic metaphase plate congression (GO:0007080) | 3.45516634 |
| 65 | deoxyribonucleotide catabolic process (GO:0009264) | 3.44085809 |
| 66 | protein complex disassembly (GO:0043241) | 3.43546899 |
| 67 | establishment of protein localization to mitochondrion (GO:0072655) | 3.43475467 |
| 68 | GTP biosynthetic process (GO:0006183) | 3.38857433 |
| 69 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.38378077 |
| 70 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.38321948 |
| 71 | IMP biosynthetic process (GO:0006188) | 3.38261905 |
| 72 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.37559198 |
| 73 | deoxyribose phosphate catabolic process (GO:0046386) | 3.37446412 |
| 74 | UTP biosynthetic process (GO:0006228) | 3.36836560 |
| 75 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.35954012 |
| 76 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.35382402 |
| 77 | protein localization to kinetochore (GO:0034501) | 3.34770049 |
| 78 | GDP-mannose metabolic process (GO:0019673) | 3.34161233 |
| 79 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.31406508 |
| 80 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.31406508 |
| 81 | NADH dehydrogenase complex assembly (GO:0010257) | 3.31406508 |
| 82 | cellular component biogenesis (GO:0044085) | 3.31198584 |
| 83 | cytochrome complex assembly (GO:0017004) | 3.29776236 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.29600776 |
| 85 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.29600776 |
| 86 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.28434861 |
| 87 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.28434861 |
| 88 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.28434861 |
| 89 | mitotic recombination (GO:0006312) | 3.27046771 |
| 90 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.26341233 |
| 91 | macromolecular complex disassembly (GO:0032984) | 3.26147783 |
| 92 | mitotic nuclear envelope disassembly (GO:0007077) | 3.25401845 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.24502337 |
| 94 | oxidative phosphorylation (GO:0006119) | 3.24314527 |
| 95 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.24139261 |
| 96 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.24139261 |
| 97 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.23156984 |
| 98 | folic acid metabolic process (GO:0046655) | 3.23129612 |
| 99 | protein localization to mitochondrion (GO:0070585) | 3.21636075 |
| 100 | telomere maintenance via telomere lengthening (GO:0010833) | 3.21535119 |
| 101 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.21163717 |
| 102 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.18690176 |
| 103 | respiratory chain complex IV assembly (GO:0008535) | 3.17773084 |
| 104 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16879279 |
| 105 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.15963918 |
| 106 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.14818775 |
| 107 | cell cycle G1/S phase transition (GO:0044843) | 3.14818775 |
| 108 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.14068330 |
| 109 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.12321620 |
| 110 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.12321620 |
| 111 | 7-methylguanosine mRNA capping (GO:0006370) | 3.12121461 |
| 112 | CENP-A containing nucleosome assembly (GO:0034080) | 3.11366228 |
| 113 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.11154693 |
| 114 | positive regulation of ligase activity (GO:0051351) | 3.10757736 |
| 115 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.09831909 |
| 116 | termination of RNA polymerase I transcription (GO:0006363) | 3.08487218 |
| 117 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.08333364 |
| 118 | transcription from RNA polymerase I promoter (GO:0006360) | 3.08125424 |
| 119 | DNA unwinding involved in DNA replication (GO:0006268) | 3.07929407 |
| 120 | protein maturation by protein folding (GO:0022417) | 3.07025141 |
| 121 | chromatin remodeling at centromere (GO:0031055) | 3.06284489 |
| 122 | 7-methylguanosine RNA capping (GO:0009452) | 3.05416227 |
| 123 | RNA capping (GO:0036260) | 3.05416227 |
| 124 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.04184190 |
| 125 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.00726866 |
| 126 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.00725594 |
| 127 | UTP metabolic process (GO:0046051) | 2.99949963 |
| 128 | rRNA methylation (GO:0031167) | 2.99488531 |
| 129 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.97572060 |
| 130 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.97572060 |
| 131 | nuclear envelope disassembly (GO:0051081) | 2.97340804 |
| 132 | membrane disassembly (GO:0030397) | 2.97340804 |
| 133 | IMP metabolic process (GO:0046040) | 2.94734038 |
| 134 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.93703387 |
| 135 | pentose metabolic process (GO:0019321) | 2.93367773 |
| 136 | peptidyl-histidine modification (GO:0018202) | 2.93318790 |
| 137 | mRNA catabolic process (GO:0006402) | 2.92111156 |
| 138 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.92040837 |
| 139 | protein localization to chromosome, centromeric region (GO:0071459) | 2.90399776 |
| 140 | RNA catabolic process (GO:0006401) | 2.86087127 |
| 141 | spliceosomal complex assembly (GO:0000245) | 2.85252820 |
| 142 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.85056618 |
| 143 | DNA replication-independent nucleosome organization (GO:0034724) | 2.81474904 |
| 144 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.81474904 |
| 145 | positive regulation of cell cycle arrest (GO:0071158) | 2.80711897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.26069322 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.34959349 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.07750640 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.28847864 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.15793094 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.14831414 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.14583636 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.10257938 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.06800399 |
| 10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.01893202 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.84441158 |
| 12 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.82886976 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.75927905 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71122558 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57952664 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.52120238 |
| 17 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.40724142 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.36846248 |
| 19 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.29107848 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27443569 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26936196 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.20463980 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.12359538 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.11335750 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.10077909 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.99901610 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97642337 |
| 28 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.96025743 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93885795 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.92982494 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90710045 |
| 32 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87346353 |
| 33 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.87275071 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76320912 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.75733183 |
| 36 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.74961251 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.74279485 |
| 38 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.72054530 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.71624506 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71320699 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68381686 |
| 42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.67537483 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61021059 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.58798596 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58293268 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55622363 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54826474 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54002534 |
| 49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51837037 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49741615 |
| 51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49130003 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47319004 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46409147 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45175482 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43342289 |
| 56 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38991953 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38325248 |
| 58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35781636 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.34976354 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32322635 |
| 61 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.28570094 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27641319 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27607633 |
| 64 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25262288 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25042557 |
| 66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24041021 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23500292 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21542142 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21195762 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21154701 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20840576 |
| 72 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20735825 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20421473 |
| 74 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16630604 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14887716 |
| 76 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13262925 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11843844 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11821367 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11634123 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10438897 |
| 81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09079550 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08795519 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07758150 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07700795 |
| 85 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.07548634 |
| 86 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07090008 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.05132466 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05029199 |
| 89 | * MAF_26560356_Chip-Seq_TH2_Human | 1.04658808 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00947211 |
| 91 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.99983618 |
| 92 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.99969648 |
| 93 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98890629 |
| 94 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98555575 |
| 95 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97081203 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96662297 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95037527 |
| 98 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93701890 |
| 99 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93525582 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93317224 |
| 101 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93295003 |
| 102 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92919903 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91303409 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91070306 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90743585 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90337381 |
| 107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90126386 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90083861 |
| 109 | * MAF_26560356_Chip-Seq_TH1_Human | 0.89607067 |
| 110 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88093755 |
| 111 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.85528660 |
| 112 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84854114 |
| 113 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.83547016 |
| 114 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83540992 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80823393 |
| 116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79347161 |
| 117 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.78539888 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.78120553 |
| 119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.77873353 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77104775 |
| 121 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76851809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.67660854 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.31351311 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.95488403 |
| 4 | MP0003077_abnormal_cell_cycle | 3.58686687 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.51824945 |
| 6 | MP0008007_abnormal_cellular_replicative | 2.73859065 |
| 7 | MP0008058_abnormal_DNA_repair | 2.67728792 |
| 8 | MP0008057_abnormal_DNA_replication | 2.56737613 |
| 9 | MP0003123_paternal_imprinting | 2.51690043 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.47612840 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.33188419 |
| 12 | MP0001730_embryonic_growth_arrest | 2.16503628 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.12111240 |
| 14 | MP0003786_premature_aging | 2.11853232 |
| 15 | MP0000490_abnormal_crypts_of | 2.02493003 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.01844840 |
| 17 | MP0003718_maternal_effect | 2.01407610 |
| 18 | MP0002163_abnormal_gland_morphology | 1.98322476 |
| 19 | MP0001873_stomach_inflammation | 1.95374456 |
| 20 | MP0000350_abnormal_cell_proliferation | 1.89470551 |
| 21 | MP0003186_abnormal_redox_activity | 1.77526481 |
| 22 | MP0010307_abnormal_tumor_latency | 1.74692675 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.63112583 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.63112583 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.56318019 |
| 26 | MP0003567_abnormal_fetal_cardiomyocyte | 1.55834065 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.55187780 |
| 28 | MP0001672_abnormal_embryogenesis/_devel | 1.53880228 |
| 29 | MP0005380_embryogenesis_phenotype | 1.53880228 |
| 30 | MP0001697_abnormal_embryo_size | 1.53716663 |
| 31 | MP0005501_abnormal_skin_physiology | 1.52515228 |
| 32 | MP0002080_prenatal_lethality | 1.48716482 |
| 33 | MP0000313_abnormal_cell_death | 1.47620402 |
| 34 | MP0002132_abnormal_respiratory_system | 1.44587959 |
| 35 | MP0003984_embryonic_growth_retardation | 1.44247466 |
| 36 | MP0005451_abnormal_body_composition | 1.41936216 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.41613436 |
| 38 | MP0002088_abnormal_embryonic_growth/wei | 1.41147583 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.39915356 |
| 40 | MP0009840_abnormal_foam_cell | 1.39111669 |
| 41 | MP0000858_altered_metastatic_potential | 1.38750388 |
| 42 | MP0002796_impaired_skin_barrier | 1.36603861 |
| 43 | MP0002019_abnormal_tumor_incidence | 1.35579163 |
| 44 | MP0001881_abnormal_mammary_gland | 1.35563037 |
| 45 | MP0000358_abnormal_cell_content/ | 1.32517577 |
| 46 | MP0002086_abnormal_extraembryonic_tissu | 1.28635466 |
| 47 | MP0006292_abnormal_olfactory_placode | 1.21371349 |
| 48 | MP0001853_heart_inflammation | 1.19787181 |
| 49 | MP0003436_decreased_susceptibility_to | 1.19746414 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.19593654 |
| 51 | MP0006054_spinal_hemorrhage | 1.18312752 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.16622165 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.16305871 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.14833438 |
| 55 | MP0005379_endocrine/exocrine_gland_phen | 1.14250743 |
| 56 | MP0009785_altered_susceptibility_to | 1.13163364 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.12775413 |
| 58 | MP0002722_abnormal_immune_system | 1.12527698 |
| 59 | MP0000685_abnormal_immune_system | 1.11726068 |
| 60 | MP0002085_abnormal_embryonic_tissue | 1.11700070 |
| 61 | MP0002398_abnormal_bone_marrow | 1.08119830 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.08058440 |
| 63 | MP0005023_abnormal_wound_healing | 1.06812516 |
| 64 | MP0001835_abnormal_antigen_presentation | 1.06502042 |
| 65 | MP0005083_abnormal_biliary_tract | 1.04377154 |
| 66 | MP0001919_abnormal_reproductive_system | 1.03475609 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01548127 |
| 68 | MP0008995_early_reproductive_senescence | 1.00368166 |
| 69 | MP0000750_abnormal_muscle_regeneration | 1.00232530 |
| 70 | * MP0002429_abnormal_blood_cell | 0.97714640 |
| 71 | MP0001661_extended_life_span | 0.97486682 |
| 72 | MP0004197_abnormal_fetal_growth/weight/ | 0.96877321 |
| 73 | MP0002084_abnormal_developmental_patter | 0.95350067 |
| 74 | MP0009697_abnormal_copulation | 0.90601465 |
| 75 | MP0001790_abnormal_immune_system | 0.90303299 |
| 76 | MP0005387_immune_system_phenotype | 0.90303299 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.89887543 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.89293994 |
| 79 | MP0002405_respiratory_system_inflammati | 0.89023513 |
| 80 | MP0001346_abnormal_lacrimal_gland | 0.88910130 |
| 81 | MP0002452_abnormal_antigen_presenting | 0.88347238 |
| 82 | MP0003705_abnormal_hypodermis_morpholog | 0.88179859 |
| 83 | MP0008469_abnormal_protein_level | 0.87670037 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.87366731 |
| 85 | MP0001542_abnormal_bone_strength | 0.87133727 |
| 86 | MP0005025_abnormal_response_to | 0.87028119 |
| 87 | * MP0001845_abnormal_inflammatory_respons | 0.86842983 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.86283908 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.85500809 |
| 90 | MP0005408_hypopigmentation | 0.85112636 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 0.84721440 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.84205887 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84172952 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.83839322 |
| 95 | MP0003866_abnormal_defecation | 0.83645704 |
| 96 | MP0005384_cellular_phenotype | 0.83581337 |
| 97 | MP0000716_abnormal_immune_system | 0.83496819 |
| 98 | MP0008873_increased_physiological_sensi | 0.82651173 |
| 99 | MP0002254_reproductive_system_inflammat | 0.82403459 |
| 100 | MP0001293_anophthalmia | 0.82224465 |
| 101 | MP0001819_abnormal_immune_cell | 0.82188473 |
| 102 | MP0002210_abnormal_sex_determination | 0.82025738 |
| 103 | MP0003448_altered_tumor_morphology | 0.81870646 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.81811923 |
| 105 | MP0005332_abnormal_amino_acid | 0.81106250 |
| 106 | MP0010030_abnormal_orbit_morphology | 0.80865471 |
| 107 | MP0001145_abnormal_male_reproductive | 0.78674069 |
| 108 | MP0003941_abnormal_skin_development | 0.78322127 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.77607000 |
| 110 | MP0002160_abnormal_reproductive_system | 0.76985176 |
| 111 | MP0008260_abnormal_autophagy | 0.76643660 |
| 112 | MP0002723_abnormal_immune_serum | 0.76450177 |
| 113 | MP0005000_abnormal_immune_tolerance | 0.76183679 |
| 114 | MP0002419_abnormal_innate_immunity | 0.75977252 |
| 115 | MP0006082_CNS_inflammation | 0.74833277 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.74076399 |
| 117 | MP0001800_abnormal_humoral_immune | 0.73796462 |
| 118 | MP0005621_abnormal_cell_physiology | 0.73790729 |
| 119 | MP0009278_abnormal_bone_marrow | 0.73136536 |
| 120 | MP0001764_abnormal_homeostasis | 0.71967635 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.71574747 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.71444401 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.68726807 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.68295606 |
| 125 | MP0009053_abnormal_anal_canal | 0.68202764 |
| 126 | MP0005389_reproductive_system_phenotype | 0.67776488 |
| 127 | MP0000343_altered_response_to | 0.66502764 |
| 128 | MP0003121_genomic_imprinting | 0.66268516 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.66110048 |
| 130 | MP0005671_abnormal_response_to | 0.65482997 |
| 131 | MP0003119_abnormal_digestive_system | 0.64239826 |
| 132 | MP0000627_abnormal_mammary_gland | 0.63576594 |
| 133 | MP0001663_abnormal_digestive_system | 0.63546958 |
| 134 | MP0001915_intracranial_hemorrhage | 0.63444298 |
| 135 | MP0001119_abnormal_female_reproductive | 0.62075991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.26716018 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.98478127 |
| 3 | Reticulocytopenia (HP:0001896) | 4.89360528 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.78498965 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.74400446 |
| 6 | Birth length less than 3rd percentile (HP:0003561) | 4.71048410 |
| 7 | Acute encephalopathy (HP:0006846) | 4.40794793 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 4.28216417 |
| 9 | Breast hypoplasia (HP:0003187) | 4.26910831 |
| 10 | Renal Fanconi syndrome (HP:0001994) | 4.09950627 |
| 11 | Increased muscle lipid content (HP:0009058) | 3.92096876 |
| 12 | Macrocytic anemia (HP:0001972) | 3.85156967 |
| 13 | Rough bone trabeculation (HP:0100670) | 3.81331924 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.68365435 |
| 15 | Oral leukoplakia (HP:0002745) | 3.61034465 |
| 16 | Multiple enchondromatosis (HP:0005701) | 3.55043944 |
| 17 | Pallor (HP:0000980) | 3.47209388 |
| 18 | Aplastic anemia (HP:0001915) | 3.45849352 |
| 19 | Abnormality of the anterior horn cell (HP:0006802) | 3.44551705 |
| 20 | Degeneration of anterior horn cells (HP:0002398) | 3.44551705 |
| 21 | Cerebral edema (HP:0002181) | 3.32822377 |
| 22 | Trismus (HP:0000211) | 3.23607733 |
| 23 | Lactic acidosis (HP:0003128) | 3.22956117 |
| 24 | Selective tooth agenesis (HP:0001592) | 3.22824299 |
| 25 | Testicular atrophy (HP:0000029) | 3.16053786 |
| 26 | Microretrognathia (HP:0000308) | 3.08150920 |
| 27 | Carpal bone hypoplasia (HP:0001498) | 3.06723557 |
| 28 | Exercise intolerance (HP:0003546) | 3.00790348 |
| 29 | Cerebral hypomyelination (HP:0006808) | 2.97548284 |
| 30 | Thrombocytosis (HP:0001894) | 2.94421002 |
| 31 | Patellar aplasia (HP:0006443) | 2.87727592 |
| 32 | Abnormal trabecular bone morphology (HP:0100671) | 2.82401901 |
| 33 | Colon cancer (HP:0003003) | 2.78352068 |
| 34 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.76597321 |
| 35 | Respiratory failure (HP:0002878) | 2.75479158 |
| 36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.68662199 |
| 37 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.68662199 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.68662199 |
| 39 | Abnormal glycosylation (HP:0012345) | 2.68662199 |
| 40 | Poor head control (HP:0002421) | 2.55915255 |
| 41 | Impulsivity (HP:0100710) | 2.54664800 |
| 42 | Premature graying of hair (HP:0002216) | 2.53889410 |
| 43 | Agnosia (HP:0010524) | 2.53437161 |
| 44 | Absent thumb (HP:0009777) | 2.52391229 |
| 45 | 11 pairs of ribs (HP:0000878) | 2.50440772 |
| 46 | Premature ovarian failure (HP:0008209) | 2.47264905 |
| 47 | Secondary amenorrhea (HP:0000869) | 2.44632537 |
| 48 | Sparse eyelashes (HP:0000653) | 2.42728301 |
| 49 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.38040984 |
| 50 | Petechiae (HP:0000967) | 2.37858617 |
| 51 | Meckel diverticulum (HP:0002245) | 2.35069968 |
| 52 | Abnormality of the umbilical cord (HP:0010881) | 2.32825148 |
| 53 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.31381951 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.31381951 |
| 55 | Lethargy (HP:0001254) | 2.30852344 |
| 56 | Bone marrow hypocellularity (HP:0005528) | 2.30465022 |
| 57 | Cleft eyelid (HP:0000625) | 2.30136031 |
| 58 | Type I transferrin isoform profile (HP:0003642) | 2.28930897 |
| 59 | Abnormality of renal resorption (HP:0011038) | 2.28833572 |
| 60 | Abnormality of the preputium (HP:0100587) | 2.28788644 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 2.27334521 |
| 62 | Neoplasm of the pancreas (HP:0002894) | 2.25056491 |
| 63 | Personality changes (HP:0000751) | 2.25026956 |
| 64 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.24441663 |
| 65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.22567931 |
| 66 | Increased serum lactate (HP:0002151) | 2.20217361 |
| 67 | Chromsome breakage (HP:0040012) | 2.20060832 |
| 68 | Cellular immunodeficiency (HP:0005374) | 2.19871822 |
| 69 | Abnormality of the ileum (HP:0001549) | 2.19349690 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.17600770 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17600770 |
| 72 | Progressive muscle weakness (HP:0003323) | 2.14686744 |
| 73 | Exertional dyspnea (HP:0002875) | 2.14625213 |
| 74 | Glossoptosis (HP:0000162) | 2.13403480 |
| 75 | Myelodysplasia (HP:0002863) | 2.13144862 |
| 76 | Pancytopenia (HP:0001876) | 2.11443141 |
| 77 | Megaloblastic anemia (HP:0001889) | 2.10718710 |
| 78 | Entropion (HP:0000621) | 2.07822350 |
| 79 | Absent radius (HP:0003974) | 2.06617334 |
| 80 | Leukodystrophy (HP:0002415) | 2.03083088 |
| 81 | Opisthotonus (HP:0002179) | 2.02827879 |
| 82 | Tracheoesophageal fistula (HP:0002575) | 2.02473754 |
| 83 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.02004521 |
| 84 | Slender long bone (HP:0003100) | 2.01517524 |
| 85 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01322709 |
| 86 | Abnormality of reticulocytes (HP:0004312) | 1.99507230 |
| 87 | IgM deficiency (HP:0002850) | 1.99218241 |
| 88 | Optic disc pallor (HP:0000543) | 1.96510289 |
| 89 | Abnormality of chromosome stability (HP:0003220) | 1.95789568 |
| 90 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.95761112 |
| 91 | Horseshoe kidney (HP:0000085) | 1.94356665 |
| 92 | Hepatocellular necrosis (HP:0001404) | 1.92541020 |
| 93 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.92404905 |
| 94 | Nausea (HP:0002018) | 1.91553866 |
| 95 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91153563 |
| 96 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91124087 |
| 97 | Methylmalonic aciduria (HP:0012120) | 1.91119610 |
| 98 | Hypoplasia of the pons (HP:0012110) | 1.90378091 |
| 99 | Microvesicular hepatic steatosis (HP:0001414) | 1.89878472 |
| 100 | Squamous cell carcinoma (HP:0002860) | 1.89027504 |
| 101 | Spinal muscular atrophy (HP:0007269) | 1.88631911 |
| 102 | Abnormality of methionine metabolism (HP:0010901) | 1.88346225 |
| 103 | Abnormality of glycolysis (HP:0004366) | 1.87637547 |
| 104 | Increased serum pyruvate (HP:0003542) | 1.87637547 |
| 105 | Absent forearm bone (HP:0003953) | 1.87200244 |
| 106 | Aplasia involving forearm bones (HP:0009822) | 1.87200244 |
| 107 | Hypertensive crisis (HP:0100735) | 1.87185724 |
| 108 | Increased CSF lactate (HP:0002490) | 1.86974533 |
| 109 | Pustule (HP:0200039) | 1.85938983 |
| 110 | Reduced antithrombin III activity (HP:0001976) | 1.83425346 |
| 111 | Generalized aminoaciduria (HP:0002909) | 1.83338344 |
| 112 | Emotional lability (HP:0000712) | 1.82688507 |
| 113 | Ureteral duplication (HP:0000073) | 1.80561825 |
| 114 | Duodenal stenosis (HP:0100867) | 1.80535790 |
| 115 | Small intestinal stenosis (HP:0012848) | 1.80535790 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.79496306 |
| 117 | Hepatic necrosis (HP:0002605) | 1.78601909 |
| 118 | Atresia of the external auditory canal (HP:0000413) | 1.78147222 |
| 119 | Hyperphosphaturia (HP:0003109) | 1.78056352 |
| 120 | CNS demyelination (HP:0007305) | 1.78002097 |
| 121 | Triphalangeal thumb (HP:0001199) | 1.77996221 |
| 122 | Muscle fiber atrophy (HP:0100295) | 1.77518006 |
| 123 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77196588 |
| 124 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76930739 |
| 125 | Obstructive lung disease (HP:0006536) | 1.76930739 |
| 126 | Mitochondrial inheritance (HP:0001427) | 1.76194455 |
| 127 | Tongue fasciculations (HP:0001308) | 1.76096615 |
| 128 | Paralysis (HP:0003470) | 1.75985581 |
| 129 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.73615859 |
| 130 | Glycosuria (HP:0003076) | 1.73497461 |
| 131 | Abnormality of urine glucose concentration (HP:0011016) | 1.73497461 |
| 132 | Abnormality of the pons (HP:0007361) | 1.73420639 |
| 133 | Recurrent abscess formation (HP:0002722) | 1.73409155 |
| 134 | Death in infancy (HP:0001522) | 1.73406003 |
| 135 | Postnatal microcephaly (HP:0005484) | 1.73320630 |
| 136 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72867787 |
| 137 | Abnormality of T cell physiology (HP:0011840) | 1.71514150 |
| 138 | Congenital, generalized hypertrichosis (HP:0004540) | 1.71334755 |
| 139 | Respiratory difficulties (HP:0002880) | 1.71062798 |
| 140 | Hepatosplenomegaly (HP:0001433) | 1.70431884 |
| 141 | Seborrheic dermatitis (HP:0001051) | 1.70032717 |
| 142 | Muscle fibrillation (HP:0010546) | 1.69760418 |
| 143 | Neutropenia (HP:0001875) | 1.68647558 |
| 144 | Increased serum ferritin (HP:0003281) | 1.65907299 |
| 145 | Hypergonadotropic hypogonadism (HP:0000815) | 1.63943572 |
| 146 | Progressive microcephaly (HP:0000253) | 1.63200771 |
| 147 | IgG deficiency (HP:0004315) | 1.61985151 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.61565397 |
| 149 | Panhypogammaglobulinemia (HP:0003139) | 1.59936876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.15708359 |
| 2 | BUB1 | 4.82240497 |
| 3 | NME2 | 4.31727056 |
| 4 | WEE1 | 4.27296661 |
| 5 | EIF2AK1 | 2.98800794 |
| 6 | PIM2 | 2.66097798 |
| 7 | STK16 | 2.56523389 |
| 8 | TSSK6 | 2.46468052 |
| 9 | NEK2 | 2.21440377 |
| 10 | PLK4 | 2.12550408 |
| 11 | EIF2AK3 | 2.08165715 |
| 12 | TESK2 | 2.07835066 |
| 13 | CDC7 | 2.06411159 |
| 14 | SMG1 | 1.97719461 |
| 15 | SRPK1 | 1.92421288 |
| 16 | EPHA2 | 1.91727839 |
| 17 | BRSK2 | 1.84879232 |
| 18 | ACVR1B | 1.80099674 |
| 19 | RPS6KA4 | 1.69241057 |
| 20 | PLK1 | 1.63765974 |
| 21 | TESK1 | 1.56283614 |
| 22 | MST4 | 1.55628442 |
| 23 | VRK1 | 1.53449799 |
| 24 | NEK1 | 1.52238702 |
| 25 | TTK | 1.48916194 |
| 26 | KDR | 1.47932642 |
| 27 | CDK7 | 1.46460294 |
| 28 | PAK4 | 1.43883551 |
| 29 | RPS6KB2 | 1.41200531 |
| 30 | DYRK3 | 1.39759269 |
| 31 | AURKB | 1.38168376 |
| 32 | TLK1 | 1.36871064 |
| 33 | PASK | 1.33892210 |
| 34 | ARAF | 1.31525382 |
| 35 | TRIB3 | 1.29495147 |
| 36 | MAP3K8 | 1.26505296 |
| 37 | MAP3K11 | 1.26428717 |
| 38 | BLK | 1.20395198 |
| 39 | TAF1 | 1.18468741 |
| 40 | BRAF | 1.17928543 |
| 41 | NUAK1 | 1.16833965 |
| 42 | AURKA | 1.15777966 |
| 43 | MKNK1 | 1.14154598 |
| 44 | TGFBR1 | 1.12849374 |
| 45 | BRSK1 | 1.09432210 |
| 46 | PLK3 | 1.08941330 |
| 47 | LRRK2 | 1.06635916 |
| 48 | PIM1 | 1.06231147 |
| 49 | ATR | 1.03033177 |
| 50 | ZAK | 1.01516959 |
| 51 | MAP2K3 | 1.00133932 |
| 52 | NME1 | 0.98922798 |
| 53 | SCYL2 | 0.98513100 |
| 54 | MUSK | 0.95538984 |
| 55 | CDK4 | 0.93333244 |
| 56 | MAP4K1 | 0.91739843 |
| 57 | PKN2 | 0.91342754 |
| 58 | PAK1 | 0.90592747 |
| 59 | DAPK1 | 0.88103972 |
| 60 | FLT3 | 0.86732603 |
| 61 | CCNB1 | 0.86628214 |
| 62 | CHEK2 | 0.85811920 |
| 63 | TAOK2 | 0.83747687 |
| 64 | STK10 | 0.83608574 |
| 65 | TXK | 0.82568286 |
| 66 | ABL2 | 0.80639733 |
| 67 | EIF2AK2 | 0.76561491 |
| 68 | MKNK2 | 0.75989206 |
| 69 | MAP3K3 | 0.74342880 |
| 70 | EEF2K | 0.74054084 |
| 71 | IRAK3 | 0.73764600 |
| 72 | ILK | 0.73672417 |
| 73 | MAP2K2 | 0.70070444 |
| 74 | ZAP70 | 0.69439145 |
| 75 | CHEK1 | 0.68556193 |
| 76 | CSNK2A1 | 0.68545991 |
| 77 | CDK19 | 0.67644400 |
| 78 | CSNK2A2 | 0.64897545 |
| 79 | MAP3K12 | 0.63346561 |
| 80 | PRKCI | 0.62783357 |
| 81 | PBK | 0.60831416 |
| 82 | STK4 | 0.60566902 |
| 83 | LIMK1 | 0.58544429 |
| 84 | DYRK2 | 0.55262067 |
| 85 | CDK8 | 0.53170081 |
| 86 | CSNK1G3 | 0.52596187 |
| 87 | MAPKAPK3 | 0.48152662 |
| 88 | BCKDK | 0.47754519 |
| 89 | CDK2 | 0.46746236 |
| 90 | BTK | 0.46667639 |
| 91 | IKBKB | 0.46577738 |
| 92 | RPS6KA5 | 0.46509572 |
| 93 | ALK | 0.46114252 |
| 94 | AKT3 | 0.44361639 |
| 95 | TEC | 0.43250048 |
| 96 | IKBKE | 0.43005558 |
| 97 | ITK | 0.42306528 |
| 98 | TBK1 | 0.41970097 |
| 99 | PDK4 | 0.41920244 |
| 100 | PDK3 | 0.41920244 |
| 101 | NEK9 | 0.40360867 |
| 102 | MAP4K2 | 0.39873802 |
| 103 | KIT | 0.39838723 |
| 104 | GRK6 | 0.39310288 |
| 105 | RAF1 | 0.39310099 |
| 106 | LATS2 | 0.39205788 |
| 107 | MAP3K10 | 0.39157824 |
| 108 | SIK1 | 0.38744845 |
| 109 | TYK2 | 0.36828660 |
| 110 | ERN1 | 0.36402097 |
| 111 | MATK | 0.35387653 |
| 112 | PRKG2 | 0.35260692 |
| 113 | DAPK3 | 0.34889675 |
| 114 | JAK3 | 0.34499199 |
| 115 | PDK2 | 0.33324467 |
| 116 | AKT2 | 0.33007101 |
| 117 | IRAK4 | 0.32697361 |
| 118 | IRAK2 | 0.32438694 |
| 119 | ATM | 0.32188136 |
| 120 | CSNK1G1 | 0.30606746 |
| 121 | MAPKAPK5 | 0.28207412 |
| 122 | LYN | 0.27036696 |
| 123 | MAPKAPK2 | 0.24187609 |
| 124 | PRKCD | 0.24127223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.60744959 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.36755471 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.27743861 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.75034450 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.59718093 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.39521823 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.87204877 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.80567445 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.78872828 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.65031468 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.52451433 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.48352088 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.08861050 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.07590822 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.05091363 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72200462 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.55382356 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52621520 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.50332398 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.47664138 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.45654372 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.42705012 |
| 23 | * Purine metabolism_Homo sapiens_hsa00230 | 1.38500415 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37085978 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36037472 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28125366 |
| 27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.25022660 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15901909 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15340860 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14096354 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03336811 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01944571 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01684113 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01128462 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97688063 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 0.95135033 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95028825 |
| 38 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95006288 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94508142 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93891273 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93874658 |
| 42 | Protein export_Homo sapiens_hsa03060 | 0.93408791 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91184155 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.88425364 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84881883 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82993573 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80163299 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78236993 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77075918 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69821952 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64767738 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.63098152 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62616321 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.61478848 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61471580 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61443948 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60998160 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.60085012 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54835534 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52902342 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52348958 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52198242 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50380361 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.48703073 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48621860 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48201420 |
| 67 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47892980 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47361455 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45953909 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45947413 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45648833 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45495087 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45223693 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41563327 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41002779 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40872293 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40548092 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39146006 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38652616 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38297040 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37373059 |
| 82 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.37366806 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.36960257 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36777224 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36593501 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36350765 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35663450 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.33520047 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33325498 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.32999560 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32408475 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32369437 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31876106 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.31744322 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30704971 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30107607 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29467615 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29127260 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29057784 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28880731 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.28372471 |
| 102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27626821 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.27438719 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.26471560 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25657886 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.25055654 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.23319377 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21778376 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21280975 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.20858277 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20671901 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20149966 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19793404 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.19258347 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.17705243 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.15285466 |
| 117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.15149973 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.14926116 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.14709369 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14432388 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14193596 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.13839819 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13026932 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.12766158 |
| 125 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.11709758 |

